South Rampart Pharma receives $1.9M NIH STTR Fast-Track Grant


South Rampart Pharma is committed to improving the lives of people suffering from acute, chronic and neuropathic pain by developing a new class of non-opioid pain medicines that do not have the toxicities found in current over the counter and prescription medicines.

Play Video

Watch our video

Upcoming Events

South Rampart Pharma receives an invitation to participate in the NIH Innovation Conference and Life Science Summit

2021 NIH Innovation Conference
(NIC – a half-day, virtual event on Monday, October 4th)
Learn More About Conference >

Life Science Summit
(LSS – a two-day virtual event Tuesday, November 9th and Wednesday, November 10th).
Learn More About Conference >

South Rampart Pharma is advancing the treatment of pain by developing new, small-molecule solutions that have the potential to overcome many risks associated with current pain medicines.



Global Need